Literature DB >> 15518882

mda-9/syntenin: recent insights into a novel cell signaling and metastasis-associated gene.

Devanand Sarkar1, Habib Boukerche, Zao-Zhong Su, Paul B Fisher.   

Abstract

PDZ (an acronym representing three proteins--postsynaptic density protein PSD95/SAP90, drosophila tumor suppressor DLGA, and tight junction protein ZO-1) domain containing proteins are adapter proteins that play indispensable roles in regulating cell growth, development, and differentiation, predominantly through their capacity to serve as central organizers of protein complexes at the plasma membrane. A recently identified member of this protein family is melanoma differentiation associated gene-9 (mda-9), also known as syntenin, which was first identified as a gene down-regulated during human melanoma differentiation as mda-9 and subsequently recognized as an interacting partner of the cell-surface heparan sulfate syndecans, syntenin. Interest in mda-9/syntenin is intensifying because of its involvement in organization of protein complexes in the plasma membranes, regulation of B cell development, intracellular trafficking and cell surface targeting, cancer metastasis, synaptic transmission, and axonal outgrowth. In this review, we discuss the identification, structure and function of mda-9/syntenin and delineate future studies to address its role in regulating key physiological and pathological processes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15518882     DOI: 10.1016/j.pharmthera.2004.08.004

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  21 in total

Review 1.  Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma.

Authors:  Paul B Fisher; Devanand Sarkar; Irina V Lebedeva; Luni Emdad; Pankaj Gupta; Moira Sauane; Zao-zhong Su; Steven Grant; Paul Dent; David T Curiel; Neil Senzer; John Nemunaitis
Journal:  Toxicol Appl Pharmacol       Date:  2006-11-23       Impact factor: 4.219

2.  Anti-apoptotic action by hypoxia inducible factor 1-alpha in human pituitary adenoma cell line, HP-75 in hypoxic condition.

Authors:  Daizo Yoshida; Kyonsong Kim; Masahiro Noha; Akira Teramoto
Journal:  J Neurooncol       Date:  2006-06-16       Impact factor: 4.130

3.  MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma.

Authors:  Swadesh K Das; Sujit K Bhutia; Belal Azab; Timothy P Kegelman; Leyla Peachy; Prasanna K Santhekadur; Santanu Dasgupta; Rupesh Dash; Paul Dent; Steven Grant; Luni Emdad; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  Cancer Res       Date:  2012-12-10       Impact factor: 12.701

4.  MDA-9/syntenin interacts with ubiquitin via a novel ubiquitin-binding motif.

Authors:  Fumihiko Okumura; Koichi Yoshida; Fei Liang; Shigetsugu Hatakeyama
Journal:  Mol Cell Biochem       Date:  2011-02-27       Impact factor: 3.396

5.  Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma.

Authors:  Swadesh K Das; Sujit K Bhutia; Upneet K Sokhi; Belal Azab; Zhao-Zhong Su; Habib Boukerche; Talha Anwar; Erika L Moen; Devasis Chatterjee; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  Cancer Res       Date:  2012-10-11       Impact factor: 12.701

6.  Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB.

Authors:  H Boukerche; H Aissaoui; C Prévost; H Hirbec; S K Das; Z-Z Su; D Sarkar; P B Fisher
Journal:  Oncogene       Date:  2010-03-15       Impact factor: 9.867

7.  Novel role of MDA-9/syntenin in regulating urothelial cell proliferation by modulating EGFR signaling.

Authors:  Santanu Dasgupta; Mitchell E Menezes; Swadesh K Das; Luni Emdad; Aleksandar Janjic; Shilpa Bhatia; Nitai D Mukhopadhyay; Chunbo Shao; Devanand Sarkar; Paul B Fisher
Journal:  Clin Cancer Res       Date:  2013-07-19       Impact factor: 12.531

8.  mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src.

Authors:  Habib Boukerche; Zao-zhong Su; Célia Prévot; Devanand Sarkar; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-02       Impact factor: 11.205

9.  MDA-9/syntenin is a key regulator of glioma pathogenesis.

Authors:  Timothy P Kegelman; Swadesh K Das; Bin Hu; Manny D Bacolod; Christine E Fuller; Mitchell E Menezes; Luni Emdad; Santanu Dasgupta; Albert S Baldwin; Jeffrey N Bruce; Paul Dent; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

Review 10.  MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis.

Authors:  Swadesh K Das; Santanu Maji; Stephen L Wechman; Praveen Bhoopathi; Anjan K Pradhan; Sarmistha Talukdar; Devanand Sarkar; Joseph Landry; Chunqing Guo; Xiang-Yang Wang; Webster K Cavenee; Luni Emdad; Paul B Fisher
Journal:  Pharmacol Res       Date:  2020-02-13       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.